Stock Price
0.87
Daily Change
-0.01 -1.14%
Monthly
-14.71%
Yearly
-66.02%
Q1 Forecast
0.84

RedHill Biopharma reported $89.8K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
Cara Therapeutics 43.75M 4.8M Jun/2025
Compugen USD 954K 116K Sep/2025
Cronos Group USD 0 7K Sep/2024
RedHill Biopharma USD 89.8K 31.69M Jun/2024